Autism Behavior Services, Inc. President Visits Texas to Advocate for Expanded Autism Care
SANTA ANA, CA, UNITED STATES, March 24, 2025 / EINPresswire.com / -- Autism Behavior Services, Inc. (ABSI) President, Andrew Patterson visited the great state of Texas in late February to advocate for expanding access to autism care services. During his visit, Andrew engaged with key lawmakers to discuss increasing the availability of essential services for families and demonstrate the success of Texas as a partner in bringing quality autism care center to those who need it most. Andrew Patterson and his son Jack Patterson had the privilege to meet with Representative Charles Cunningham, who serves on the Health Committee to discuss access for autism services.
'Texas is renowned for its commitment to providing strong special needs services,' said Andrew Patterson, President of ABSI. 'We are proud to recognize Texas as a key partner as we champion the expansion of autism care, ensuring families across the state can access much-needed resources and support.'
Autism Behavior Services, Inc. was founded by Dr. Rosa Patterson, Psy.D., in 2010 with the mission of improving the quality of life for individuals on the autism spectrum. ABSI offers industry-leading Applied Behavior Analysis (ABA) services, employing a highly trained team of Behavior Technicians, all certified in CPR and either ABAT or RBT, ensuring the highest standard of care for their clients.
The visit to Texas focused on two critical advocacy points:
● Expanding Access to Families in Need: Advocating for more policies that will help families across Texas receive affordable, top-quality care to improve outcomes for children on the autism spectrum.
● Celebrating Collaboration and Progress: Highlighting Texas' role as a strong partner in ABSI's mission to expand access to care, setting an example for other states nationwide.
Autism Treatment in Austin include individualized program development, home, school, virtual-based interventions, parent training, and direct care in community settings. With a proven track record of excellence, ABSI brings tailored care and evidence-based solutions to families, empowering children on the spectrum to reach their highest potential.
The visit aligns with ABSI's goal of bridging gaps in access to care through collaboration with stakeholders, parents, and lawmakers. His efforts reinforce the agency's belief that every child deserves access to best-in-class care, regardless of geographical or financial barriers.
For questions or media inquiries, please contact:
Autism Behavior Services, Inc.
Email: [email protected]
Phone: (877) 581-7798
Address: 2080 N. Tustin Ave, Santa Ana, CA 92705
For more information on Autism Behavior Services, Inc. please visit autismbehaviorservices.com.
Evan Jacobs
Autism Behavior Services, Inc.:
+1 855-581-0100
email us here
Legal Disclaimer:
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
2 hours ago
- Business Wire
SCH Capital Holdings, Inc. Adds Health Care Compensation Management Technology Capability to Portfolio
CHICAGO--(BUSINESS WIRE)--SCH Capital Holdings, Inc., the nation's leading human capital information management holding company for health care and not-for-profit/tax-exempt organizations, has acquired Boston-based Statera. "When we combine Statera's focus on academic medical centers alongside Clinician Nexus's integrated delivery systems expertise, we are able to serve the entire health care marketplace with specialized compensation management expertise in both segments." Formed in 2020, Statera is a group of human-focused compensation experts and health care technologists who provide timely and actionable compensation and care insights to hospitals, medical groups, and clinicians. Statera's platform offers a comprehensive suite of tools that optimize clinical team performance and automate compensation administration. Statera will continue to enable health systems to automate physician compensation through its technology platform as part of Clinician Nexus, a SCH Capital Holdings, Inc. technology company. Together, these combined capabilities will provide health care organizations with a broad mix of technology tools that empower health systems and medical groups to align compensation, productivity, and incentives for their physicians and APPs. 'When we combine Statera's focus on academic medical centers alongside Clinician Nexus's integrated delivery systems expertise, we are able to serve the entire health care marketplace with specialized compensation management expertise in both segments,' said Ted Chien, President and CEO of SCH Capital Holdings, Inc. 'We are excited to join the SCH Capital Holdings, Inc., family and integrate our expertise into the Clinician Nexus brand,' said Amy Jackson, CEO of Statera. 'The company's gold standard reputation and Clinician Nexus's established platform will enable us to reach new markets. Together, we'll be able to deliver the next generation of compensation management technology to a broader audience and make a greater impact across the health care ecosystem.' About SCH Capital Holdings, Inc. SCH Capital Holdings, Inc., is the parent company of independent operating brands SullivanCotter, Clinician Nexus, Lotis Blue Consulting and C3 Nonprofit Consulting Group. This collection of complementary brands helps organizations solve complex workforce issues by enabling people, processes and technology aimed at large-scale business transformation. For more information, email info@ or call 888.739.7039.
Business Wire
3 hours ago
- Business Wire
Butterfly Network Advances AI-Powered Aortic Valve and Aorta Screening with New Research and Training Tools
BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY), a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced its role in new research demonstrating the potential for machine learning (ML) models to support early detection of aortic stenosis (AS) using handheld ultrasound devices. The study, conducted by Tufts Medical Center and published in European Heart Journal – Imaging Methods and Practice, demonstrates that a ML model fine-tuned for use on Butterfly iQ+ devices can achieve high accuracy in identifying AS. The findings support the value of ML model development, and ultimately, are a positive step toward portable screening for earlier detection of this life-threatening condition. Aortic stenosis, a narrowing of the aortic valve, affects over 13% of Americans over 75 years old and is often missed until it's advanced and symptomatic. Studies(1, 2) suggest that a significant number of AS cases remain undiagnosed, particularly among underserved and aging populations. This delay in diagnosis is associated with higher risk procedures, worse outcomes, and increased healthcare costs. As earlier identification and treatments of AS are increasingly associated with better patient outcomes, the need for upstream, accessible screening is critical. 'This research shows a promising path forward where lower-level providers, not just cardiologists or trained sonographers, could screen for aortic stenosis using AI-assisted handheld ultrasound,' said Dr. John Martin, co-author of the study and Butterfly's Chief Medical Officer Emeritus. 'This opens the door to early detection in a wide variety of care venues including primary care offices, long term care facilities, urgent care facilities and even in the home.' The study validated that an ML model trained on hospital-grade ultrasound images performed well when adapted to Butterfly's handheld ultrasound device. After fine-tuning the final layer of a neural network, researchers achieved an area under the receiver operator characteristic curve (AUROC) of 0.94 for differentiating between no aortic stenosis and any degree of aortic stenosis on handheld ultrasound images – a level of accuracy that supports potential clinical use in screening workflows. In a related development, Butterfly has just released the latest expansion of its Butterfly ScanLab™ AI-powered ultrasound education app: an Aorta Exam Protocol. This educational app harnesses animations, anatomical labeling, and a quality indicator to help teach users how to scan the abdominal aorta and recognize normal anatomy. With that training, users can then use POCUS to detect life-threatening conditions like abdominal aortic aneurysms (AAA) and dissections. Designed for ease of use on an iPad, the module is included in every Butterfly membership and compatible with existing Butterfly probes. Joseph DeVivo, President, CEO, and Chairman of Butterfly Network concluded, 'Early detection saves lives, but access to imaging remains a major barrier. This work is about democratizing diagnostics. With AI and education working hand in hand, we're empowering more providers to deliver proactive care in places that were never possible before.' About Butterfly Network Butterfly Network, Inc. (NYSE: BFLY) is a healthcare company driving a digital revolution in medical imaging with its proprietary Ultrasound-on-Chip™ semiconductor technology and ultrasound software solutions. In 2018, Butterfly launched the world's first handheld, single-probe, whole-body ultrasound system, Butterfly iQ. The iQ+ followed in 2020, and the iQ3 in 2024, each with improved processing power and performance by leveraging Moore's Law. The iQ3 earned Best Medical Technology at the 2024 Prix Galien USA Awards, a prestigious honor and one of the highest accolades in healthcare. Butterfly's innovations have also been recognized by Fierce 50, TIME's Best Inventions and Fast Company's World Changing Ideas, among other achievements. Butterfly combines advanced hardware, intelligent software, AI, services, and education to drive adoption of affordable, accessible imaging. Clinical publications demonstrate that its handheld ultrasound probes paired with Compass™ enterprise workflow software, can help hospital systems improve care workflows, reduce costs, and enhance provider economics. With a cloud-based solution that enables care anywhere through next-generation mobility, Butterfly aims to democratize healthcare by addressing critical global healthcare challenges. Butterfly devices are commercially available to trained healthcare practitioners in areas including, but not limited to, parts of Africa, Asia, Australia, Europe, the Middle East, North America and South America; to learn more about available countries, visit:
Business Wire
3 hours ago
- Business Wire
Spok-Powered Hospitals Achieve Recognition on U.S. News & World Report's Best Hospitals Honor Roll
PLANO, Texas--(BUSINESS WIRE)-- Spok, Inc., a wholly owned subsidiary of Spok Holdings, Inc. (NASDAQ: SPOK) and a global leader in healthcare communications, today reported that 18 of the 20 adult hospitals featured on the 2025-26 U.S. News & World Report Best Hospitals Honor Roll use Spok technology to enhance care coordination and deliver outstanding patient experiences. For over 10 years, nearly all the top-ranking hospitals have consistently leveraged Spok solutions. 'When our healthcare partners lead with distinction, we celebrate alongside them. This recognition truly represents the incredible work happening in hospitals across the country, and we are proud and honored to be part of that journey,' said Vincent D. Kelly, chief executive officer of Spok Holdings, Inc. 'Their deep commitment to clinical excellence inspires everything we do to improve patient care, strengthen teamwork, and ultimately save lives.' The honorees represent a selection of the over 2,200 hospitals nationwide that rely on Spok solutions to eliminate communication barriers, streamline workflows, and enhance patient experiences. As the global authority on hospital rankings, the U.S. News & World Report has compiled the 2025-26 U.S. News & World Report Best Hospitals Honor Roll for over three decades. This recognition program evaluates approximately 4,500 healthcare organizations annually, naming 20 of the country's highest-performing hospitals among 15 specialties and 22 procedures and conditions. The rankings are based primarily on a methodology that analyzes care-related indicators such as mortality, unplanned readmissions, infection prevention, prolonged hospitalizations, nurse staffing and communication, patient experience, and timely treatments. About Spok Spok, Inc., a wholly owned subsidiary of Spok Holdings, Inc. (NASDAQ: SPOK), headquartered in Plano, Texas, is proud to be a global leader in healthcare communications. We deliver clinical information to care teams when and where it matters most to improve patient outcomes. Top hospitals rely on the Spok Care Connect® platform to enhance workflows for clinicians and support administrative compliance. Our customers send over 70 million messages each month through their Spok® solutions. Spok enables smarter, faster clinical communication. For more information, visit
